Two cases of probable Neuro-Behçet syndrome treated with autologous HSCT - Summary - MDSpire

Two cases of probable Neuro-Behçet syndrome treated with autologous HSCT

  • By

  • Charlotte Schubert

  • Lea I. Walter

  • Marina Herwerth

  • Imke Metz

  • Jakob Nilsson

  • Ilijas Jelcic

  • Patrick Roth

  • Nicolaus Kröger

  • Ina Kötter

  • Christoph Heesen

  • Vivien Häußler

  • Veronika Kana

  • July 13, 2026

Share

Objective:

To report the clinical course, treatment strategies, and responses of two cases with probable Neuro-Behçet syndrome (NBS).

Approach:
  • Case Description: Two cases of probable NBS were described, detailing their clinical presentations, diagnostic challenges, and treatment responses.
Key Findings:
  • Both cases presented with longitudinally extensive transverse myelitis and brainstem lesions.
  • Recurrent relapses and disease progression were resistant to multiple immunotherapies.
  • Autologous hematopoietic stem cell transplantation (aHSCT) did not confer clinical benefit in either case.
Interpretation:

NBS should be considered in patients with myelitis and brainstem involvement who have limited treatment response. The cases highlight diagnostic challenges and the heterogeneity of disease presentation.

Limitations:
  • The diagnostic criteria for NBS are less well defined compared to Behçet syndrome.
  • Limited evidence exists guiding the treatment of NBS, particularly regarding aHSCT.
Conclusion:

Further studies are required to optimize therapeutic strategies for NBS.

Original Source(s)

Related Content